TP Miller

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

William S. Dalton, Thomas M. Grogan, Paul S. Meltzer et al. · Journal of Clinical Oncology · 1989 · 560 citations

Medicine, Oncology, Pharmacology +15

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

TP Miller, Thomas M. Grogan, William S. Dalton et al. · Journal of Clinical Oncology · 1991 · 385 citations

Medicine, Oncology, Pharmacology +15

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

Dennis O. Dixon, Barbara A. Neilan, Siân Jones et al. · Journal of Clinical Oncology · 1986 · 362 citations

Medicine, Geriatric Medicine, Oncology +15

A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study

R I Fisher, Steve Dahlberg, BN Nathwani et al. · Blood · 1995 · 347 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

TP Miller, TM Grogan, Steve Dahlberg et al. · Blood · 1994 · 239 citations · Full text

Veterinary Medicine, Oncology, Pathology +9